市場調査レポート

商品コード

1349437

創薬アウトソーシング市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Drug Discovery Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: 2023年07月07日 | 発行: Transparency Market Research

| ページ情報: 英文 214 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 908,424円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,378,704円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,848,984円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

創薬アウトソーシング市場- レポートの範囲

世界の創薬アウトソーシング市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの創薬アウトソーシングの世界市場の収益を掲載しています。また、2023年から2031年までの世界の創薬アウトソーシング市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、創薬アウトソーシング市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値	36億米ドル
2031年の市場価値	75億米ドル
CAGR	7.8%

このレポートは、世界の創薬アウトソーシング市場の競合情勢を詳しく掘り下げています。世界の創薬アウトソーシング市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の創薬アウトソーシング市場のプレーヤーの属性です。

イントロダクションと定義
主な発見/開発
市場金額予測：ワークフロー別、2017-2031
- ターゲットの特定とスクリーニング
- リードの特定と候補の最適化
- 疾患モデルの開発
- 製剤化前の研究
- 臨床試験全体
- その他
市場魅力分析：ワークフロー別

第11章世界市場の分析と予測：エンドユーザー別

イントロダクションと定義
主な発見/開発
市場金額予測：エンドユーザー別、2017-2031
- 製薬会社
- バイオテクノロジー企業
- 学術機関
市場魅力分析：エンドユーザー別

第12章世界市場の分析と予測：地域別

主な調査結果
市場金額予測：地域別、2017-2031
- 北米
- 欧州
- アジア太平洋地域
- ラテンアメリカ
- 中東・アフリカ
市場魅力分析：地域別

第13章北米市場の分析と予測

第14章欧州市場の分析と予測

第15章アジア太平洋市場の分析と予測

第16章ラテンアメリカ市場の分析と予測

第17章中東およびアフリカ市場の分析と予測

第18章競合情勢

市場企業- 競争マトリックス（企業の階層および規模別）
市場シェア分析：企業別（2022年）
企業プロファイル
- Charles River Laboratories International, Inc.
- WuXi AppTec Co., Ltd.
- Albany Molecular Research Inc.
- GVK Biosciences Private Limited
- Sygnature Discovery
- Pharmaron Beijing Co., Ltd.
- Domainex Ltd.
- Thermo Fisher Scientific, Inc.
- Jubilant Biosys Ltd.
- Evotec SE
- Eurofins Discovery
- GenScript Biotech Corporation

図表

List of Tables

Table 01: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 02: Global Drug Discovery Outsourcing Market Value (`) Forecast, by Drug Molecule, 2017-2031
Table 03: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 04: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 05: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 06: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 07: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Region, 2017-2031
Table 08: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 09: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 10: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 11: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 12: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 13: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 14: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country, 2017-2031
Table 15: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 16: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 17: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 18: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 19: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 20: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 21: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 23: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 24: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 25: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 26: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 27: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 28: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 29: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 30: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 31: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 32: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 33: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 34: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 35: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 36: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 37: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 38: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 39: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 40: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 41: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 42: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

Figure 01: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 02: Global Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 03: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 04: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Target Identification and Screening, 2017-2031
Figure 05: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Lead Identification and Candidate Optimization, 2017-2031
Figure 06: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Development of Disease Models, 2017-2031
Figure 07: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Pre-formulation Studies, 2017-2031
Figure 08: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Entire Clinical Trials, 2017-2031
Figure 09: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Others, 2017-2031
Figure 10: Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 11: Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 12: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Small Molecules, 2017-2031
Figure 13: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Large Molecules, 2017-2031
Figure 14: Global Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 15: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Empirical Drug Discovery, 2017-2031
Figure 16: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Rational Drug Discovery, 2017-2031
Figure 17: Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 18: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Anti-infective, 2017-2031
Figure 19: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Cardiovascular, 2017-2031
Figure 20: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Central Nervous System, 2017-2031
Figure 21: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Dermatology, 2017-2031
Figure 22: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Endocrine, 2017-2031
Figure 23: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Gastrointestinal, 2017-2031
Figure 24: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Genitourinary System, 2017-2031
Figure 25: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Immunomodulation, 2017-2031
Figure 26: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Oncology, 2017-2031
Figure 27: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Ophthalmology, 2017-2031
Figure 28: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Respiratory System, 2017-2031
Figure 29: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Others, 2017-2031
Figure 30: Global Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 31: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 32: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Chemistry Services, 2017-2031
Figure 33: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Biology Services, 2017-2031
Figure 34: Global Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 35: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 36: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Pharmaceutical Companies, 2017-2031
Figure 37: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Biotechnology Companies, 2017-2031
Figure 38: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Academic Institutes, 2017-2031
Figure 39: Global Drug Discovery Outsourcing Market Value Share Analysis, by Region, 2022 and 2031
Figure 40: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region, 2022-2031
Figure 41: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 42: North America Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 43: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 44: North America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 45: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 46: North America Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 47: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 48: North America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 49: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 50: North America Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 51: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 52: North America Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 53: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 54: North America Drug Discovery Outsourcing Market Value Share Analysis, by Country, 2022 and 2031
Figure 55: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country, 2022-2031
Figure 56: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 57: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 58: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 59: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 60: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 61: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 62: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 63: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 64: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 65: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 66: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 67: Europe Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 68: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 69: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 70: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 71: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 72: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 73: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 74: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 75: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 76: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 77: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 78: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 79: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 80: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 81: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 82: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 83: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 84: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 85: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 86: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 87: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 88: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 89: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 90: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 91: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 92: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 93: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 94: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 95: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 96: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 97: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 98: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 99: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 100: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 101: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 102: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 103: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 104: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 105: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 106: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 107: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 108: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 109: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 110: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 111: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 112: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 113: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 114: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 115: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031

Product Code: TMRGL1841

Drug Discovery Outsourcing Market - Scope of Report

TMR's report on the global drug discovery outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global drug discovery outsourcing market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug discovery outsourcing market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug discovery outsourcing market.

Market Snapshot
Market Value in 2023	US$ 3.6 Bn
Market Value in 2031	US$ 7.5 Bn
CAGR	7.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug discovery outsourcing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug discovery outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug discovery outsourcing market.

The report delves into the competitive landscape of the global drug discovery outsourcing market. Key players operating in the global drug discovery outsourcing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug discovery outsourcing market profiled in this report.

Key Questions Answered in Global Drug Discovery Outsourcing Market Report:

What is the sales/revenue generated by drug discovery outsourcing across all regions during the forecast period?
What are the opportunities in the global drug discovery outsourcing market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Drug Discovery Outsourcing Market - Research Objectives and Research Approach

The comprehensive report on the global drug discovery outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug discovery outsourcing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug discovery outsourcing market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug Discovery Outsourcing Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Drug Discovery Outsourcing Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Technological Advancements
5.2. Overview: Integrated Drug Discovery (IDD) outsourcing
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Type

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017-2031
- 6.3.1. Chemistry Services
- 6.3.2. Biology Services
6.4. Market Attractiveness Analysis, by Type

7. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Drug Molecule

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Drug Molecule, 2017-2031
- 7.3.1. Small Molecules
- 7.3.2. Large Molecules
7.4. Market Attractiveness Analysis, by Drug Molecule

8. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Discovery Approach

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Discovery Approach, 2017-2031
- 8.3.1. Empirical Drug Discovery
- 8.3.2. Rational Drug Discovery
8.4. Market Attractiveness Analysis, by Discovery Approach

9. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Therapeutic Area

9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Therapeutic Area, 2017-2031
- 9.3.1. Anti-infective
- 9.3.2. Cardiovascular
- 9.3.3. Central Nervous System
- 9.3.4. Dermatology
- 9.3.5. Endocrine
- 9.3.6. Gastrointestinal
- 9.3.7. Genitourinary System
- 9.3.8. Immunomodulation
- 9.3.9. Oncology
- 9.3.10. Ophthalmology
- 9.3.11. Respiratory System
- 9.3.12. Others
9.4. Market Attractiveness Analysis, by Therapeutic Area

10. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Workflow

10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by Workflow, 2017-2031
- 10.3.1. Target Identification and Screening
- 10.3.2. Lead Identification and Candidate Optimization
- 10.3.3. Development of Disease Models
- 10.3.4. Pre-formulation Studies
- 10.3.5. Entire Clinical Trials
- 10.3.6. Others
10.4. Market Attractiveness Analysis, by Workflow

11. Global Drug Discovery Outsourcing Market Analysis and Forecast, by End-user

11.1. Introduction & Definition
11.2. Key Findings/Developments
11.3. Market Value Forecast, by Discovery Approach, 2017-2031
- 11.3.1. Pharmaceutical Companies
- 11.3.2. Biotechnology Companies
- 11.3.3. Academic Institutes
11.4. Market Attractiveness Analysis, by End-user

12. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Region

12.1. Key Findings
12.2. Market Value Forecast, by Region, 2017-2031
- 12.2.1. North America
- 12.2.2. Europe
- 12.2.3. Asia Pacific
- 12.2.4. Latin America
- 12.2.5. Middle East & Africa
12.3. Market Attractiveness Analysis, by Region

13. North America Drug Discovery Outsourcing Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
- 13.2.1. Chemistry Services
- 13.2.2. Biology Services
13.3. Market Value Forecast, by Drug Molecule, 2017-2031
- 13.3.1. Small Molecules
- 13.3.2. Large Molecules
13.4. Market Value Forecast, by Discovery Approach, 2017-2031
- 13.4.1. Empirical Drug Discovery
- 13.4.2. Rational Drug Discovery
13.5. Market Value Forecast, by Therapeutic Area, 2017-2031
- 13.5.1. Anti-infective
- 13.5.2. Cardiovascular
- 13.5.3. Central Nervous System
- 13.5.4. Dermatology
- 13.5.5. Endocrine
- 13.5.6. Gastrointestinal
- 13.5.7. Genitourinary System
- 13.5.8. Immunomodulation
- 13.5.9. Oncology
- 13.5.10. Ophthalmology
- 13.5.11. Respiratory System
- 13.5.12. Others
13.6. Market Value Forecast, by Workflow, 2017-2031
- 13.6.1. Target Identification and Screening
- 13.6.2. Lead Identification and Candidate Optimization
- 13.6.3. Development of Disease Models
- 13.6.4. Pre-formulation Studies
- 13.6.5. Entire Clinical Trials
- 13.6.6. Others
13.7. Market Value Forecast, by End-user, 2017-2031
- 13.7.1. Pharmaceutical Companies
- 13.7.2. Biotechnology Companies
- 13.7.3. Academic Institutes
13.8. Market Value Forecast, by Country, 2017-2031
- 13.8.1. U.S.
- 13.8.2. Canada
13.9. Market Attractiveness Analysis
- 13.9.1. By Type
- 13.9.2. By Drug Molecule
- 13.9.3. By Discovery Approach
- 13.9.4. By Therapeutic Area
- 13.9.5. By Workflow
- 13.9.6. By End-user
- 13.9.7. By Country

14. Europe Drug Discovery Outsourcing Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2031
- 14.2.1. Chemistry Services
- 14.2.2. Biology Services
14.3. Market Value Forecast, by Drug Molecule, 2017-2031
- 14.3.1. Small Molecules
- 14.3.2. Large Molecules
14.4. Market Value Forecast, by Discovery Approach, 2017-2031
- 14.4.1. Empirical Drug Discovery
- 14.4.2. Rational Drug Discovery
14.5. Market Value Forecast, by Therapeutic Area, 2017-2031
- 14.5.1. Anti-infective
- 14.5.2. Cardiovascular
- 14.5.3. Central Nervous System
- 14.5.4. Dermatology
- 14.5.5. Endocrine
- 14.5.6. Gastrointestinal
- 14.5.7. Genitourinary System
- 14.5.8. Immunomodulation
- 14.5.9. Oncology
- 14.5.10. Ophthalmology
- 14.5.11. Respiratory System
- 14.5.12. Others
14.6. Market Value Forecast, by Workflow, 2017-2031
- 14.6.1. Target Identification and Screening
- 14.6.2. Lead Identification and Candidate Optimization
- 14.6.3. Development of Disease Models
- 14.6.4. Pre-formulation Studies
- 14.6.5. Entire Clinical Trials
- 14.6.6. Others
14.7. Market Value Forecast, by End-user, 2017-2031
- 14.7.1. Pharmaceutical Companies
- 14.7.2. Biotechnology Companies
- 14.7.3. Academic Institutes
14.8. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.8.1. Germany
- 14.8.2. U.K.
- 14.8.3. France
- 14.8.4. Italy
- 14.8.5. Spain
- 14.8.6. Rest of Europe
14.9. Market Attractiveness Analysis
- 14.9.1. By Type
- 14.9.2. By Drug Molecule
- 14.9.3. By Discovery Approach
- 14.9.4. By Therapeutic Area
- 14.9.5. By Workflow
- 14.9.6. By End-user
- 14.9.7. By Country/Sub-region

15. Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017-2031
- 15.2.1. Chemistry Services
- 15.2.2. Biology Services
15.3. Market Value Forecast, by Drug Molecule, 2017-2031
- 15.3.1. Small Molecules
- 15.3.2. Large Molecules
15.4. Market Value Forecast, by Discovery Approach, 2017-2031
- 15.4.1. Empirical Drug Discovery
- 15.4.2. Rational Drug Discovery
15.5. Market Value Forecast, by Therapeutic Area, 2017-2031
- 15.5.1. Anti-infective
- 15.5.2. Cardiovascular
- 15.5.3. Central Nervous System
- 15.5.4. Dermatology
- 15.5.5. Endocrine
- 15.5.6. Gastrointestinal
- 15.5.7. Genitourinary System
- 15.5.8. Immunomodulation
- 15.5.9. Oncology
- 15.5.10. Ophthalmology
- 15.5.11. Respiratory System
- 15.5.12. Others
15.6. Market Value Forecast, by Workflow, 2017-2031
- 15.6.1. Target Identification and Screening
- 15.6.2. Lead Identification and Candidate Optimization
- 15.6.3. Development of Disease Models
- 15.6.4. Pre-formulation Studies
- 15.6.5. Entire Clinical Trials
- 15.6.6. Others
15.7. Market Value Forecast, by End-user, 2017-2031
- 15.7.1. Pharmaceutical Companies
- 15.7.2. Biotechnology Companies
- 15.7.3. Academic Institutes
15.8. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.8.1. China
- 15.8.2. Japan
- 15.8.3. India
- 15.8.4. Australia & New Zealand
- 15.8.5. Rest of Asia Pacific
15.9. Market Attractiveness Analysis
- 15.9.1. By Type
- 15.9.2. By Drug Molecule
- 15.9.3. By Discovery Approach
- 15.9.4. By Therapeutic Area
- 15.9.5. By Workflow
- 15.9.6. By End-user
- 15.9.7. By Country/Sub-region

16. Latin America Drug Discovery Outsourcing Market Analysis and Forecast

16.1. Introduction
- 16.1.1. Key Findings
16.2. Market Value Forecast, by Type, 2017-2031
- 16.2.1. Chemistry Services
- 16.2.2. Biology Services
16.3. Market Value Forecast, by Drug Molecule, 2017-2031
- 16.3.1. Small Molecules
- 16.3.2. Large Molecules
16.4. Market Value Forecast, by Discovery Approach, 2017-2031
- 16.4.1. Empirical Drug Discovery
- 16.4.2. Rational Drug Discovery
16.5. Market Value Forecast, by Therapeutic Area, 2017-2031
- 16.5.1. Anti-infective
- 16.5.2. Cardiovascular
- 16.5.3. Central Nervous System
- 16.5.4. Dermatology
- 16.5.5. Endocrine
- 16.5.6. Gastrointestinal
- 16.5.7. Genitourinary System
- 16.5.8. Immunomodulation
- 16.5.9. Oncology
- 16.5.10. Ophthalmology
- 16.5.11. Respiratory System
- 16.5.12. Others
16.6. Market Value Forecast, by Workflow, 2017-2031
- 16.6.1. Target Identification and Screening
- 16.6.2. Lead Identification and Candidate Optimization
- 16.6.3. Development of Disease Models
- 16.6.4. Pre-formulation Studies
- 16.6.5. Entire Clinical Trials
- 16.6.6. Others
16.7. Market Value Forecast, by End-user, 2017-2031
- 16.7.1. Pharmaceutical Companies
- 16.7.2. Biotechnology Companies
- 16.7.3. Academic Institutes
16.8. Market Value Forecast, by Country/Sub-region, 2017-2031
- 16.8.1. Brazil
- 16.8.2. Mexico
- 16.8.3. Rest of Latin America
16.9. Market Attractiveness Analysis
- 16.9.1. By Type
- 16.9.2. By Drug Molecule
- 16.9.3. By Discovery Approach
- 16.9.4. By Therapeutic Area
- 16.9.5. By Workflow
- 16.9.6. By End-user
- 16.9.7. By Country/Sub-region

17. Middle East & Africa Drug Discovery Outsourcing Market Analysis and Forecast

17.1. Introduction
- 17.1.1. Key Findings
17.2. Market Value Forecast, by Type, 2017-2031
- 17.2.1. Chemistry Services
- 17.2.2. Biology Services
17.3. Market Value Forecast, by Drug Molecule, 2017-2031
- 17.3.1. Small Molecules
- 17.3.2. Large Molecules
17.4. Market Value Forecast, by Discovery Approach, 2017-2031
- 17.4.1. Empirical Drug Discovery
- 17.4.2. Rational Drug Discovery
17.5. Market Value Forecast, by Therapeutic Area, 2017-2031
- 17.5.1. Anti-infective
- 17.5.2. Cardiovascular
- 17.5.3. Central Nervous System
- 17.5.4. Dermatology
- 17.5.5. Endocrine
- 17.5.6. Gastrointestinal
- 17.5.7. Genitourinary System
- 17.5.8. Immunomodulation
- 17.5.9. Oncology
- 17.5.10. Ophthalmology
- 17.5.11. Respiratory System
- 17.5.12. Others
17.6. Market Value Forecast, by Workflow, 2017-2031
- 17.6.1. Target Identification and Screening
- 17.6.2. Lead Identification and Candidate Optimization
- 17.6.3. Development of Disease Models
- 17.6.4. Pre-formulation Studies
- 17.6.5. Entire Clinical Trials
- 17.6.6. Others
17.7. Market Value Forecast, by End-user, 2017-2031
- 17.7.1. Pharmaceutical Companies
- 17.7.2. Biotechnology Companies
- 17.7.3. Academic Institutes
17.8. Market Value Forecast, by Country/Sub-region, 2017-2031
- 17.8.1. GCC Countries
- 17.8.2. South Africa
- 17.8.3. Rest of MEA
17.9. Market Attractiveness Analysis
- 17.9.1. By Type
- 17.9.2. By Drug Molecule
- 17.9.3. By Discovery Approach
- 17.9.4. By Therapeutic Area
- 17.9.5. By Workflow
- 17.9.6. By End-user
- 17.9.7. By Country/Sub-region

18. Competition Landscape

18.1. Market Player - Competitive Matrix (by tier and size of companies)
18.2. Market Share Analysis, by Company (2022)
18.3. Company Profiles
- 18.3.1. Charles River Laboratories International, Inc.
  - 18.3.1.1. Company Overview
  - 18.3.1.2. Product Portfolio
  - 18.3.1.3. SWOT Analysis
  - 18.3.1.4. Financial Overview
  - 18.3.1.5. Strategic Overview
- 18.3.2. WuXi AppTec Co., Ltd.
  - 18.3.2.1. Company Overview
  - 18.3.2.2. Product Portfolio
  - 18.3.2.3. SWOT Analysis
  - 18.3.2.4. Financial Overview
  - 18.3.2.5. Strategic Overview
- 18.3.3. Albany Molecular Research Inc.
  - 18.3.3.1. Company Overview
  - 18.3.3.2. Product Portfolio
  - 18.3.3.3. SWOT Analysis
  - 18.3.3.4. Financial Overview
  - 18.3.3.5. Strategic Overview
- 18.3.4. GVK Biosciences Private Limited
  - 18.3.4.1. Company Overview
  - 18.3.4.2. Product Portfolio
  - 18.3.4.3. SWOT Analysis
  - 18.3.4.4. Financial Overview
  - 18.3.4.5. Strategic Overview
- 18.3.5. Sygnature Discovery
  - 18.3.5.1. Company Overview
  - 18.3.5.2. Product Portfolio
  - 18.3.5.3. SWOT Analysis
  - 18.3.5.4. Financial Overview
  - 18.3.5.5. Strategic Overview
- 18.3.6. Pharmaron Beijing Co., Ltd.
  - 18.3.6.1. Company Overview
  - 18.3.6.2. Product Portfolio
  - 18.3.6.3. SWOT Analysis
  - 18.3.6.4. Financial Overview
  - 18.3.6.5. Strategic Overview
- 18.3.7. Domainex Ltd.
  - 18.3.7.1. Company Overview
  - 18.3.7.2. Product Portfolio
  - 18.3.7.3. SWOT Analysis
  - 18.3.7.4. Financial Overview
  - 18.3.7.5. Strategic Overview
- 18.3.8. Thermo Fisher Scientific, Inc.
  - 18.3.8.1. Company Overview
  - 18.3.8.2. Product Portfolio
  - 18.3.8.3. SWOT Analysis
  - 18.3.8.4. Financial Overview
  - 18.3.8.5. Strategic Overview
- 18.3.9. Jubilant Biosys Ltd.
  - 18.3.9.1. Company Overview
  - 18.3.9.2. Product Portfolio
  - 18.3.9.3. SWOT Analysis
  - 18.3.9.4. Financial Overview
  - 18.3.9.5. Strategic Overview
- 18.3.10. Evotec SE
  - 18.3.10.1. Company Overview
  - 18.3.10.2. Product Portfolio
  - 18.3.10.3. SWOT Analysis
  - 18.3.10.4. Financial Overview
  - 18.3.10.5. Strategic Overview
- 18.3.11. Eurofins Discovery
  - 18.3.11.1. Company Overview
  - 18.3.11.2. Product Portfolio
  - 18.3.11.3. SWOT Analysis
  - 18.3.11.4. Financial Overview
  - 18.3.11.5. Strategic Overview
- 18.3.12. GenScript Biotech Corporation
  - 18.3.12.1. Company Overview
  - 18.3.12.2. Product Portfolio
  - 18.3.12.3. SWOT Analysis
  - 18.3.12.4. Financial Overview
  - 18.3.12.5. Strategic Overview

創薬アウトソーシング市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Drug Discovery Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

創薬アウトソーシング市場- レポートの範囲

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 主要な洞察

第6章 世界市場の分析と予測：タイプ別

第7章 世界市場の分析と予測：薬剤分子別

第8章 世界市場の分析と予測：ディスカバリーアプローチ別

第9章 世界市場の分析と予測：治療領域別

第10章 世界市場の分析と予測：ワークフロー別

第11章 世界市場の分析と予測：エンドユーザー別

第12章 世界市場の分析と予測：地域別

第13章 北米市場の分析と予測

第14章 欧州市場の分析と予測

第15章 アジア太平洋市場の分析と予測

第16章 ラテンアメリカ市場の分析と予測

第17章 中東およびアフリカ市場の分析と予測

第18章 競合情勢